Integrated Research logo

IRI - Integrated Research Share Price

A$2.12 -0.1  -3.2%

Last Trade - 26/02/21

Small Cap
Market Cap £204.7m
Enterprise Value £207.8m
Revenue £51.6m
Position in Universe 466th / 1832
Unlock IRI Revenue
Relative Strength (%)
1m -14.4%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -56.9%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
70.3 84.5 91.2 91.2 100.8 110.9 84.6 95.9 +9.6%
+66.9 +12.0 +15.5 +3.4 +13.9 +9.8 -58.4 +86.2
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 31 December 2020,Integrated Research Limited revenues decreased 36% toA$34.1M. Net income decreased 99% to A$129K. Revenuesreflect Unified Communications segment decrease of 32% toA$20.1M, Infrastructure segment decrease of 50% to A$5.6M,Americas segment decrease of 28% to A$24.7M, Asia Pacificsegment decrease of 56% to A$4.1M. Net income also reflectsOther losses increase from A$112K to A$3M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for IRI
Graphical History


IRI Revenue Unlock IRI Revenue

Net Income

IRI Net Income Unlock IRI Revenue

Normalised EPS

IRI Normalised EPS Unlock IRI Revenue

PE Ratio Range

IRI PE Ratio Range Unlock IRI Revenue

Dividend Yield Range

IRI Dividend Yield Range Unlock IRI Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
IRI EPS Forecasts Unlock IRI Revenue
Profile Summary

Integrated Research Limited is a provider of performance monitoring, diagnostics and management software solutions for business-critical computing environments. The Company's principal activities are the design, development, implementation and sale of systems and applications management computer software for business-critical computing, unified communication (UC) network and payment networks. Its geographical segments include the Americas, which operates from the United States with responsibility for the countries in North, Central and South America; Europe, which operates from the United Kingdom with responsibility for the countries in Europe; Asia Pacific, which operates from the Australia and Singapore with responsibility for the countries in the rest of the world, and Corporate Australia. It is focused on three markets: Infrastructure, which includes users of computing systems; Communications, which includes users of Internet Protocol telephony and UC applications, and Payments.

Last Annual June 30th, 2020
Last Interim December 31st, 2020
Incorporated August 3, 1988
Public Since December 13, 2000
No. of Shareholders: 6,715
No. of Employees: 266
Sector Technology
Industry Software & IT Services
Index S&P/ASX All Ordinaries , S&P/ASX 300 , ASX Small Ordinaries ,
Exchange Australian Stock Exchange - SEATS
Shares in Issue 171,861,000
Free Float (0.0%)
Eligible for
IRI Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for IRI
Upcoming Events for IRI
Frequently Asked Questions for Integrated Research
What is the Integrated Research share price?

As of 26/02/21, shares in Integrated Research are trading at A$2.12, giving the company a market capitalisation of £204.7m. This share price information is delayed by 15 minutes.

How has the Integrated Research share price performed this year?

Shares in Integrated Research are currently trading at A$2.12 and the price has moved by -26.9% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Integrated Research price has moved by -29.04% over the past year.

What are the analyst and broker recommendations for Integrated Research?

Of the analysts with advisory recommendations for Integrated Research, there are there are currently 0 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Integrated Research is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Integrated Research next release its financial results?

Integrated Research is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Integrated Research dividend yield?

The Integrated Research dividend yield is 1.77% based on the trailing twelve month period.

Does Integrated Research pay a dividend?

Last year, Integrated Research paid a total dividend of 0.04, and it currently has a trailing dividend yield of 1.77%. Looking ahead, Integrated Research has not announced an ex-dividend date yet.

When does Integrated Research next pay dividends?

Integrated Research has yet to annouce their ex-dividend date. The historic dividend yield on Integrated Research shares is currently 1.77%.

How do I buy Integrated Research shares?

To buy shares in Integrated Research you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Integrated Research?

Shares in Integrated Research are currently trading at A$2.12, giving the company a market capitalisation of £204.7m.

Where are Integrated Research shares listed? Where are Integrated Research shares listed?

Here are the trading details for Integrated Research:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: IRI
What kind of share is Integrated Research?

Based on an overall assessment of its quality, value and momentum, Integrated Research is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Integrated Research share price forecast 2021?

Shares in Integrated Research are currently priced at A$2.12. At that level they are trading at 29.72% discount to the analyst consensus target price of 0.00.

Analysts covering Integrated Research currently have a consensus Earnings Per Share (EPS) forecast of 0.058 for the next financial year.

How can I tell whether the Integrated Research share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Integrated Research. Over the past six months, the relative strength of its shares against the market has been -55.43%. At the current price of A$2.12, shares in Integrated Research are trading at -38.81% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Integrated Research PE Ratio?

The Integrated Research PE ratio based on its reported earnings over the past 12 months is 29.58. The shares are currently trading at A$2.12.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Integrated Research?

Integrated Research's management team is headed by:

David Purdue - SEC
Peter Adams - CFO
Peter Lloyd - NID
Garry Dinnie - NID
Nick Abrahams - NID
Paul Brandling - NEC
Kevin Ryder - CMO
John Ruthven - CEO
Matt Glasner - OTH
Michael Tomkins - CTO
Vanessa Walker - OTH
Allan Brackin - NID
Who are the major shareholders of Integrated Research?

Here are the top five shareholders of Integrated Research based on the size of their shareholding:

Killelea (Stephen John) Individual Investor
Percentage owned: 30.13% (51.9m shares)
Rutherford (Andrew Rhys) Individual Investor
Percentage owned: 1.62% (2.79m shares)
Vanguard Investments Australia Ltd. Investment Advisor
Percentage owned: 0.87% (1.50m shares)
Debenham (Nicholas Barry) Individual Investor
Percentage owned: 0.86% (1.49m shares)
Vanguard Australian Shares Index Fund Mutual Fund
Percentage owned: 0.78% (1.34m shares)
Similar to IRI
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.